Michela Notarangelo

Dr. Michela Notarangelo


Research Focus & Metrics

Academic Career Length

8Years (2019-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
5 February 2024 in The EMBO Journal
Verified
Journal Article
Open access
Alessandro AlaimoAlessandro Alaimo
Alessandro Alaimo
SGSacha Genovesi
Sacha Genovesi
NANicole Annesi
Nicole Annesi
DFDario De Felice
Dario De Felice
SSSaurav Subedi
Saurav Subedi
ALAndrea Lunardi
Andrea Lunardi
Inflammation is a common condition of prostate tissue, whose impact on carcinogenesis is highly debated. Microbial colonization is a well-documented cause of a small percentage of prostatitis cases, but it remains unclear what underlies the majority of sterile inflammation reported. Here, androgen- independent fluctuations of PSA expression in prostate cells have lead us to identify a prominent function of the Transient Receptor Potential Cation Channel Subfamily M Member 8 (TRPM8) gene in sterile inflammation. Prostate cells secret TRPM8 RNA into extracellular vesicles (EVs), which primes TLR3/NF-kB-mediated inflammatory signaling after EV endocytosis by epithelial cancer cells. Furthermore, prostate cancer xenografts expressing a translation-defective form of TRPM8 RNA contain less collagen type I in the extracellular matrix, significantly more infiltrating NK cells, and larger necrotic areas as compared to control xenografts. These findings imply sustained, androgen-independent expression of TRPM8 constitutes as a promoter of anticancer innate immunity, which may constitute a clinically relevant condition affecting prostate cancer prognosis.

Verified
Journal Article
Open access
PDF file
SRSimona Ruggieri
Simona Ruggieri
MGMichelina De Giorgis
Michelina De Giorgis
Tiziana AnneseTiziana Annese
Tiziana Annese
RTRoberto Tamma
Roberto Tamma
ANAngelo Notarangelo
Angelo Notarangelo
BNBeatrice Nico
Beatrice Nico
Background: Dp71 is the most abundant dystrophin (DMD) gene product in the nervous system. Mutation in the Dp71 coding region is associated with cognitive disturbances in Duchenne muscular dystrophy (DMD) patients, but the function of dystrophin Dp71 in tumor progression remains to be established. This study investigated Dp71 expression in glioblastoma, the most common and aggressive primary tumor of the central nervous system (CNS). Methods: Dp71 expression was analyzed by immunofluorescence, immunohistochemistry, RT-PCR, and immunoblotting in glioblastoma cell lines and cells isolated from human glioblastoma multiforme (GBM) bioptic specimens. Results: Dp71 isoform was expressed in normal human astrocytes (NHA) cell lines and decreased in glioblastoma cell lines and cells isolated from human glioblastoma multiforme bioptic specimens. Moreover, Dp71 was localized in the nucleus in normal cells, while it was localized into the cytoplasm of glioblastoma cells organized in clusters. We have shown, by double labeling, that Dp71 colocalizes with lamin B in normal astrocytes cells, confirming the roles of Dp71 and lamin B in maintaining nuclear architecture. Finally, we demonstrated that decreased Dp71 protein in cells isolated from human bioptic specimens was inversely correlated with the Ki-67 tumor proliferative index. Conclusion: A decreased Dp71 expression is associated with cancer proliferation and poor prognosis in glioblastoma.

25 April 2024 in Oncogene
Verified
Journal Article
Closed access
PDF file
GMGiovanna Mangiapane
Giovanna Mangiapane
MNMichela Notarangelo
Michela Notarangelo
GCGiulia Canarutto
Giulia Canarutto
FFFabrizio Fabbiano
Fabrizio Fabbiano
Emiliano DallaEmiliano Dalla
Emiliano Dalla
Gianluca TellGianluca Tell
Gianluca Tell

Verified
Journal Article
Open access
PDF file
VBValentina Biagini
Valentina Biagini
FBFederica Busi
Federica Busi
VAViviana Anelli
Viviana Anelli
EKEmanuela Kerschbamer
Emanuela Kerschbamer
MBMarta Baghini
Marta Baghini
Maria Caterina  MioneMaria Caterina Mione
Maria Caterina Mione
Extracellular vesicles (EVs) are membranous particles released by all cell types. Their role as functional carrier of bioactive molecules is boosted by cells that actively secrete them in biological fluids or in the intercellular space (interstitial EVs, iEVs). Here we have optimised a method for the isolation and characterization of zebrafish iEVs from whole melanoma tissues. Zebrafish melanoma iEVs are around 140 nm in diameter, as determined by nanoparticle tracking and transmission electron microscopy (TEM) analysis. Western blot analysis shows enrichment for CD63 and Alix in the iEV fraction, but not in melanoma cell lysates. Super resolution and confocal microscopy reveal that purified zebrafish iEVs are green fluorescent protein positive (GFP+), indicating that they integrate the oncogene GFP-HRASV12G used to induce melanoma in this model within their vesicular membrane or luminal content. Analysis of RNA-Seq data found 118 non-coding (nc)RNAs differentially distributed between zebrafish melanoma and their iEVs, with only 17 of them being selectively enriched in iEVs. Among these, the RNA components of RNAses P and MRP, which process ribosomal RNA precursors, mitochondrial RNAs, and some mRNAs, were enriched in zebrafish and human melanoma EVs, but not in iEVs extracted from brain tumours. We found that melanoma iEVs induce an inflammatory response when injected in larvae, with increased expression of interferon responsive genes, and this effect is reproduced by MRP- or P-RNAs injected into circulation. This suggests that zebrafish melanoma iEVs are a source of MRP- and P-RNAs that can trigger inflammation in cells of the innate immune system.

6 July 2021 in Genes
Verified
Journal Article
Open access
PDF file
PTPaola Tesolin
Paola Tesolin
AMAnna Morgan
Anna Morgan
MNMichela Notarangelo
Michela Notarangelo
RORocco Pio Ortore
Rocco Pio Ortore
MCMaria Pina Concas
Maria Pina Concas
Giorgia GirottoGiorgia Girotto
Giorgia Girotto
Hearing loss (HL) is the most frequent sensory disorder, affecting about 1–3 per 1000 live births, with more than half of the cases attributable to genetic causes. Despite the fact that many HL causative genes have already been identified, current genetic tests fail to provide a diagnosis for about 40% of the patients, suggesting that other causes still need to be discovered. Here, we describe a four-generation Italian family affected by autosomal dominant non-syndromic hearing loss (ADNSHL), in which exome sequencing revealed a likely pathogenic variant in NCOA3 (NM_181659.3, c.2909G>C, p.(Gly970Ala)), a gene recently described as a novel candidate for ADNSHL in a Brazilian family. A comparison between the two families highlighted a series of similarities: both the identified variants are missense, localized in exon 15 of the NCOA3 gene and lead to a similar clinical phenotype, with non-syndromic, sensorineural, bilateral, moderate to profound hearing loss, with a variable age of onset. Our findings (i.e., the identification of the second family reported globally with HL caused by a variant in NCOA3) further support the involvement of NCOA3 in the etiopathogenesis of ADNSHL, which should, thus, be considered as a new gene for autosomal dominant non-syndromic hearing loss.

5 March 2020 in bioRxiv
Verified
Preprint
Open access
PDF file
ASAlessia Soldano
Alessia Soldano
LWLina Worpenberg
Lina Worpenberg
CPChiara Paolantoni
Chiara Paolantoni
SLSara Longhi
Sara Longhi
MMMiriam M. Mulorz
Miriam M. Mulorz
JRJean-Yves Roignant
Jean-Yves Roignant
N6-methyladenosine (m 6 A) regulates a variety of physiological processes through modulation of RNA metabolism. The modification is particularly enriched in the nervous system of several species, and its dysregulation has been associated with neurodevelopmental defects and neural dysfunctions. In Drosophila , loss of m 6 A alters fly behavior albeit the underlying mechanism and the role of m 6 A during nervous system development have remained elusive. Here we find that impairment of the m 6 A pathway leads to axonal overgrowth and misguidance at larval neuromuscular junctions as well as in the adult mushroom bodies. We identify Ythdf as the main m 6 A reader in the nervous system being required for limiting axonal growth. Mechanistically, we show that Ythdf directly interacts with Fragile X mental retardation protein to inhibit the translation of key transcripts involved in axonal growth regulation. Altogether, this study demonstrates that the m 6 A pathway controls development of the nervous system by modulating Fmr1 target selection.